Wolters Kluwer clinical surveillance leads Best in KLAS ratings for third time in four years
KLAS Research ranks Wolters Kluwer’s Sentri7 #1 for Infection Control & Monitoring
Media
André Rebelo
Public Affairs & Public Relations Director
Wolters Kluwer
+1 (781) 392-2411
andre.rebelo@wolterskluwer.com
Wolters Kluwer Health today announced that KLAS Research has recognized the Sentri7® clinical surveillance solution as Best in KLAS® for infection control and monitoring in the 2025 Best in KLAS – Software and Services report. KLAS Research, which specializes in monitoring and reporting the performance of healthcare solution providers, rated Sentri7 as the market leader for infection control for hospitals and health systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250205649842/en/
Wolters Kluwer Health's Sentri7 ranks #1 for infection control & monitoring in the 2025 Best in KLAS report from KLAS Research. (Graphic: Business Wire)
“We are honored that KLAS has once again recognized Wolters Kluwer’s Sentri7 team as the top-ranked infection control and monitoring solution,” said Karen Kobelski, Vice President and General Manager for Clinical Surveillance, Compliance & Data Solutions at Wolters Kluwer Health. “While the pandemic may be behind us, infection preventionists (IPs) are still managing workloads with expanded reporting requirements for hospital respiratory data and increased hospital acquired infections. We’re proud of our partner hospitals using Sentri7 to help address their evolving infection prevention needs.”
Customers report reduced IP workload burdens & more automated reporting compliance
KLAS continually interviews thousands of healthcare professionals and leverages the responses to rate innovative surveillance software. Interview questions span the areas of Culture, Loyalty, Operations, Product Features, Relationship, and Value. Customers responded to this year’s survey noting a number of key benefits for using Sentri7, including automated compliance workflows and features that save busy infection preventionists hours of work:
“…Sentri7 Infection Prevention’s strength is real-time data collection, and I like being able to submit data directly from the program to NHSN [National Healthcare Safety Network]. That is going to be a lifesaver for us.”
--KLAS user comment from a healthcare organization manager about Sentri7 for Infection Control & Monitoring, March 2024
“The biggest thing with our EHR is that Sentri7 Infection Prevention allows us to get things out of our EHR that we were never able to do without Wolters Kluwer. My infection-prevention monitoring and surveillance process was completely manual before, and we did not have antibiotic-utilization or antibiotic-resistance capabilities in our EHR. With Sentri7 Infection Prevention, I have all that, so I can very quickly look at numerous patients. What would have taken me ten hours manually before takes me one hour with Sentri7 Infection Prevention. It is a huge time saver.”
--KLAS user comment from a healthcare organization director about Sentri7 for Infection Control & Monitoring, December 2024
Sentri7 infection control and monitoring is tailored for infection preventionists
Wolters Kluwer Sentri7 is tailored to deliver alerts in real-time with evidence-based guidance helping clinical teams deliver the right care at the right time. Even with today’s electronic health records (EHRs), hospitals still face challenges identifying at-risk populations and optimizing infection prevention (IP) and control programs. Sentri7 advanced technology leverages data from the EHR and delivers an IP-tailored workflow to automate infection control and required regulatory reporting. Sentri7 is backed by a team of expert IPs continually working to responsively support changes such as the National Healthcare Safety Network (NHSN) new HRD requirements in 2024. Through continuous content updates and delivering insights into key workflows, Sentri7 helps teams with saving time, identifying infections proactively, and complying with reporting requirements.
Sentri7 infection prevention and monitoring stands out as Best in KLAS
Best in KLAS is a prestigious award program that recognizes health technology solution providers for outstanding efforts to help healthcare professionals deliver better patient care. The Best in KLAS designation is reserved for the software and services market segments that have the broadest operational and clinical impact on healthcare organizations.
Adam Gale, CEO at KLAS Research commented, “Congratulations to the 2025 winners of the Best in KLAS awards! Winning a Best in KLAS award signifies a commitment to delivering outstanding value and innovation to healthcare providers and patients alike. It is my hope that these awards inspire the winners and other companies to reach new heights.”
For more information about Wolters Kluwer, please visit: www.wolterskluwer.com.
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250205649842/en/
